Published in Thorax on December 16, 2013
Catheter-Directed Therapy in Acute Pulmonary Embolism with Right Ventricular Dysfunction: A Promising Modality to Provide Early Hemodynamic Recovery. Med Sci Monit (2016) 0.83
Timing of discharge follow-up for acute pulmonary embolism: retrospective cohort study. West J Emerg Med (2015) 0.79
Analysis of Risk Factors for Lower-limb Deep Venous Thrombosis in Old Patients after Knee Arthroplasty. Chin Med J (Engl) (2015) 0.78
Treacherous Travelers: Emboli. Am J Med (2015) 0.75
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism. PLoS One (2016) 0.75
Pathways for outpatient management of venous thromboembolism in a UK centre. Thromb J (2016) 0.75
Prominent cerebral veins on susceptibility-weighted imaging (SWI) in pulmonary embolism. Eur Radiol (2016) 0.75
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J (2008) 12.31
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med (2009) 9.17
Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med (2002) 8.28
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med (2013) 7.76
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med (1998) 7.08
Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med (2013) 7.00
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet (2011) 6.25
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation (2005) 5.38
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16
Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation (1999) 4.46
Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol (2003) 4.10
Treatment of right heart thromboemboli. Chest (2002) 3.86
Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke (2001) 3.58
The European Cooperative Study on the clinical significance of right heart thrombi. European Working Group on Echocardiography. Eur Heart J (1989) 3.09
Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol (2009) 2.79
Surgical or medical treatment for thrombus straddling the patent foramen ovale: impending paradoxical embolism? Report of four clinical cases and literature review. Arch Cardiovasc Dis (2008) 2.76
Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). Am J Cardiol (2012) 2.55
Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg (2005) 2.53
Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med (2005) 2.51
Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost (2010) 2.43
Massive pulmonary embolism. Circulation (2006) 2.27
Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med (2010) 2.23
Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation (1999) 2.13
Early and late clinical outcomes of pulmonary embolectomy for acute massive pulmonary embolism. Ann Thorac Surg (2010) 2.11
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood (2005) 2.07
Changes in PESI scores predict mortality in intermediate-risk patients with acute pulmonary embolism. Eur Respir J (2012) 2.03
Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol (1996) 2.01
Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest (2006) 1.99
Massive pulmonary embolism in a patient undergoing Cesarean delivery. J Clin Anesth (2012) 1.97
Diagnosis and initial management of acute stroke and transient ischaemic attack: summary of NICE guidance. BMJ (2008) 1.95
Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg (1987) 1.95
Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol (2011) 1.87
Floating right heart thrombi and pulmonary embolism: diagnosis, outcome and therapeutic management. Cardiology (1996) 1.82
Venous thromboembolism after acute stroke. Stroke (2001) 1.81
Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke (2010) 1.80
Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med (2008) 1.54
Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood (2013) 1.51
Improved midterm outcomes for type A (central) pulmonary emboli treated surgically. J Thorac Cardiovasc Surg (2011) 1.49
Diagnosis and management of subsegmental pulmonary embolism. J Thromb Haemost (2006) 1.47
Off-label intravenous thrombolysis in acute stroke. Eur J Neurol (2011) 1.44
Mobile thrombi of the right heart in pulmonary embolism: delayed disappearance after thrombolytic treatment. Chest (2005) 1.41
Anticoagulation for atrial fibrillation: should warfarin be temporarily stopped or continued after acute cardioembolic stroke? Age Ageing (2010) 1.40
Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism. J Thromb Haemost (2012) 1.39
Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost (2008) 1.36
Congenital and acquired pulmonary artery anomalies in the adult: radiologic overview. Radiographics (2006) 1.35
Prospective evaluation of unsuspected pulmonary embolism on contrast enhanced multidetector CT (MDCT) scanning. Thorax (2006) 1.33
Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax (2010) 1.30
Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res (2000) 1.28
Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol (1997) 1.25
Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy--should surgical indications be revisited? Eur J Cardiothorac Surg (2012) 1.22
Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol (2006) 1.21
Unsuspected pulmonary embolism: prospective detection on routine helical CT scans. Radiology (1998) 1.20
Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke (2005) 1.19
Excellent outcome after surgical treatment of massive pulmonary embolism in critically ill patients. J Thorac Cardiovasc Surg (2008) 1.17
Outcome of pulmonary embolectomy. Am J Cardiol (2006) 1.17
Novel approach for the management of sub-massive pulmonary embolism. Ann Thorac Med (2012) 1.11
Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke (2001) 1.09
Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. Am J Cardiol (2002) 1.06
Diagnosis and management of isolated subsegmental pulmonary embolism: review and assessment of the options. Clin Appl Thromb Hemost (2011) 1.06
Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thromb Res (2010) 1.04
Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis. Thromb Res (2013) 1.03
Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci (2011) 0.98
Giant right atrial thrombi treated with thrombolysis. Can J Cardiol (2008) 0.97
Multiple congenital anomalies associated with oral anticoagulants. Am J Obstet Gynecol (1977) 0.95
Successful management of acute pulmonary embolism after surgery for lung cancer. Eur J Cardiothorac Surg (2003) 0.95
Bronchial artery dilatation on MDCT scans of patients with acute pulmonary embolism: comparison with chronic or recurrent pulmonary embolism. AJR Am J Roentgenol (2004) 0.94
Concomitant submassive pulmonary embolism and paradoxical embolic stroke after a long flight: which is the optimal treatment? J Cardiovasc Med (Hagerstown) (2008) 0.94
Impact of rescue-thrombolysis during cardiopulmonary resuscitation in patients with pulmonary embolism. PLoS One (2009) 0.90
Systemic thrombolytic therapy after recent abdominal aortic aneurysm repair: an absolute contraindication? Mayo Clin Proc (2003) 0.89
Thrombolysis with recombinant tissue plasminogen activator during cardiopulmonary resuscitation in fulminant pulmonary embolism. A case series. Resuscitation (2001) 0.88
The prevalence of symptomatic and coincidental pulmonary embolism on computed tomography. J Comput Assist Tomogr (2008) 0.87
Right heart thrombi: consider the cause. Can J Cardiol (2008) 0.86
Thrombolytics for cardiac arrest: case report and systematic review of controlled trials. Ann Pharmacother (2010) 0.84
Low molecular weight heparin versus aspirin for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis (2007) 0.84
The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism. Intensive Care Med (1996) 0.84
Thrombolysis for ischemic stroke in patients with brain tumors. J Stroke Cerebrovasc Dis (2013) 0.84
Emergency pulmonary embolectomy during the second trimester of pregnancy: report of a case. Surg Today (2007) 0.84
Successful thrombolysis of major pulmonary embolism 5 days after lobectomy. Interact Cardiovasc Thorac Surg (2012) 0.84
Orbital haemorrhage complication following postoperative thrombolysis. Br J Ophthalmol (2003) 0.83
Catheter-based therapies for massive pulmonary embolism. Prog Cardiovasc Dis (2010) 0.82
Inhaled nitric oxide improves pulmonary functions following massive pulmonary embolism: a report of four patients and review of the literature. Lung (2006) 0.82
Computed tomography for the detection of free-floating thrombi in the right heart in acute pulmonary embolism. Eur Radiol (2010) 0.81
Pilot study of a protocol to administer inhaled nitric oxide to treat severe acute submassive pulmonary embolism. Emerg Med J (2013) 0.80
Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe. Int J Stroke (2012) 0.79
No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial. BMC Pulm Med (2010) 0.79
Pulmonary embolism after lung resection: diagnosis and treatment. Ann Thorac Surg (2003) 0.79
Intraoperative thrombolysis in a patient with cardiopulmonary arrest undergoing caesarean delivery. Anaesth Intensive Care (2011) 0.79
New oral anticoagulants in the treatment of pulmonary embolism: efficacy, bleeding risk, and monitoring. Thrombosis (2013) 0.78
Management of a massive pulmonary embolism in a pregnant patient with mechanical fragmentation followed by delayed catheter-directed thrombolysis in the early postpartum period. J Matern Fetal Neonatal Med (2008) 0.77
The complications of cardioembolic stroke: lessons from the VISTA database. Cerebrovasc Dis (2008) 0.76
Systemic thrombolysis for prosthetic valve thrombosis in the immediate postoperative period of major abdominal surgery. J Thorac Cardiovasc Surg (2007) 0.76
Thrombolysis for acute submassive pulmonary embolism: CON viewpoint. Thorax (2013) 0.76
Early postoperative thrombolytic therapy after laparotomy. Resuscitation (2001) 0.76
Successful thrombolysis after pulmonary endarterectomy. Ann Thorac Surg (2010) 0.76
Inhaled iloprost for severe pulmonary hypertension. N Engl J Med (2002) 3.90
Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med (2008) 3.67
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med (2012) 2.00
TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J Leukoc Biol (2011) 1.98
Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res (2006) 1.86
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia. Am J Respir Crit Care Med (2014) 1.73
Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. Thromb Haemost (2008) 1.67
Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med (2008) 1.52
emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension. Eur Respir J (2013) 1.52
Normal prothrombin time in the presence of therapeutic levels of rivaroxaban. Br J Haematol (2012) 1.48
Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish. Blood (2013) 1.48
Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J Clin Invest (2011) 1.44
The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. Am J Respir Med (2002) 1.38
Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension. Invest Radiol (2012) 1.30
Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J (2006) 1.30
The expression and roles of Toll-like receptors in the biology of the human neutrophil. J Leukoc Biol (2005) 1.26
Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost (2005) 1.23
Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J (2012) 1.16
Agonists of toll-like receptors 2 and 4 activate airway smooth muscle via mononuclear leukocytes. Am J Respir Crit Care Med (2005) 1.16
The role of TLRs in neutrophil activation. Curr Opin Pharmacol (2011) 1.15
Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. J Immunol (2004) 1.12
Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. J Immunol (2007) 1.12
Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages. Infect Immun (2011) 1.11
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.11
Effective caspase inhibition blocks neutrophil apoptosis and reveals Mcl-1 as both a regulator and a target of neutrophil caspase activation. PLoS One (2011) 1.08
"Dirty little secrets"--endotoxin contamination of recombinant proteins. Immunol Lett (2006) 1.06
NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing. Thorax (2012) 1.05
Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms. J Biol Chem (2010) 1.05
Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. J Leukoc Biol (2006) 1.04
Granulocyte apoptosis in the pathogenesis and resolution of lung disease. Clin Sci (Lond) (2006) 1.03
Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa. Am J Respir Crit Care Med (2007) 1.03
Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, pyocyanin. J Immunol (2008) 1.01
A Bayesian approach to copy-number-polymorphism analysis in nuclear pedigrees. Am J Hum Genet (2007) 1.01
Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol (2003) 1.01
The role of interleukin-1beta in direct and toll-like receptor 4-mediated neutrophil activation and survival. Am J Pathol (2004) 0.99
Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient. J Thromb Thrombolysis (2010) 0.99
CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol (2002) 0.99
Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson (2012) 0.98
Protamine reversal of low molecular weight heparin: clinically effective? Blood Coagul Fibrinolysis (2011) 0.97
CCR4 blockade does not inhibit allergic airways inflammation. J Leukoc Biol (2003) 0.97
Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. J Exp Med (2012) 0.97
Role of interleukin-1 and MyD88-dependent signaling in rhinovirus infection. J Virol (2011) 0.97
Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. Am J Pathol (2011) 0.97
Decreased whole body endogenous nitric oxide production in patients with primary pulmonary hypertension. J Vasc Res (2005) 0.94
Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology (Oxford) (2009) 0.93
Toll-like receptors and chronic lung disease. Clin Sci (Lond) (2005) 0.93
Pulmonary hypertension: diagnosis and management. BMJ (2013) 0.93
Cavitating lung lesions in chronic thromboembolic pulmonary hypertension. J Radiol Case Rep (2008) 0.93
Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol (2011) 0.92
Endotoxin tolerance induces selective alterations in neutrophil function. J Leukoc Biol (2005) 0.92
Characterization of nitric oxide consumption pathways by normal, chronic granulomatous disease and myeloperoxidase-deficient human neutrophils. J Immunol (2002) 0.92
Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program. Pediatr Res (2008) 0.92
Roles of neutrophils in the regulation of the extent of human inflammation through delivery of IL-1 and clearance of chemokines. J Leukoc Biol (2012) 0.91
Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood (2007) 0.91
Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter. J Immunol (2003) 0.90
Staphylococcus aureus induces eosinophil cell death mediated by α-hemolysin. PLoS One (2012) 0.90
A central role for monocytes in Toll-like receptor-mediated activation of the vasculature. Immunology (2009) 0.89
The generation of highly purified primary human neutrophils and assessment of apoptosis in response to Toll-like receptor ligands. Methods Mol Biol (2009) 0.88
Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension. Circ Cardiovasc Imaging (2013) 0.88
A phosphatidylserine species inhibits a range of TLR- but not IL-1beta-induced inflammatory responses by disruption of membrane microdomains. J Immunol (2008) 0.88
Reducing the toll of inflammatory lung disease. Chest (2007) 0.88
Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils. J Biol Chem (2002) 0.88
Pellino-1 selectively regulates epithelial cell responses to rhinovirus. J Virol (2012) 0.87
Incapacitating the immune system in cystic fibrosis. Nat Med (2007) 0.85
Basic science of the innate immune system and the lung. Paediatr Respir Rev (2008) 0.85
Supplementation of iron in pulmonary hypertension: Rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension. Pulm Circ (2013) 0.85
3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry. Thorax (2013) 0.84
Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT. Radiology (2012) 0.83
CXCR1+CD4+ T cells in human allergic disease. J Immunol (2004) 0.83
CT pulmonary angiography combined with echocardiography in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology (Oxford) (2011) 0.83
Differential and cell-type specific regulation of responses to Toll-like receptor agonists by ISO-1. Immunology (2008) 0.83
The role of interleukin-1 and interleukin-18 in pro-inflammatory and anti-viral responses to rhinovirus in primary bronchial epithelial cells. PLoS One (2013) 0.83
9alpha,11beta-PGF2 and its stereoisomer PGF2alpha are novel agonists of the chemoattractant receptor, CRTH2. FEBS Lett (2005) 0.83
Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension. Pulm Circ (2012) 0.82
The identification, characterization, and distribution of guinea pig CCR4 and epitope mapping of a blocking antibody. J Biol Chem (2001) 0.82
Ex vivo-expanded bone marrow CD34+ derived neutrophils have limited bactericidal ability. Stem Cells (2008) 0.82
Primary pulmonary artery sarcoma and coexisting chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med (2013) 0.82
Experimental validation of the hyperpolarized (129) Xe chemical shift saturation recovery technique in healthy volunteers and subjects with interstitial lung disease. Magn Reson Med (2014) 0.81
Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art. J Thorac Imaging (2014) 0.80